178 related articles for article (PubMed ID: 29372939)
1. Can Statins Diminish Depression?
Singh D; Lippmann S
Prim Care Companion CNS Disord; 2018 Jan; 20(1):. PubMed ID: 29372939
[TBL] [Abstract][Full Text] [Related]
2. Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression.
Tsai SJ
Med Hypotheses; 2007; 68(6):1296-9. PubMed ID: 17097821
[TBL] [Abstract][Full Text] [Related]
3. Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.
Zuzarte P; Duong A; Figueira ML; Costa-Vitali A; Scola G
Curr Drug Metab; 2018; 19(8):674-687. PubMed ID: 29512447
[TBL] [Abstract][Full Text] [Related]
4. Do Statins Have Antidepressant Effects?
Köhler-Forsberg O; Gasse C; Berk M; Østergaard SD
CNS Drugs; 2017 May; 31(5):335-343. PubMed ID: 28303466
[TBL] [Abstract][Full Text] [Related]
5. Statins in the treatment of depression: Hype or hope?
Köhler-Forsberg O; Otte C; Gold SM; Østergaard SD
Pharmacol Ther; 2020 Nov; 215():107625. PubMed ID: 32652185
[TBL] [Abstract][Full Text] [Related]
6. Statins: Neurobiological underpinnings and mechanisms in mood disorders.
Walker AJ; Kim Y; Borissiouk I; Rehder R; Dodd S; Morris G; Nierenberg AA; Maes M; Fernandes BS; Dean OM; Williams LJ; Eyre HA; Kim SW; Zoungas S; Carvalho AF; Berk M
Neurosci Biobehav Rev; 2021 Sep; 128():693-708. PubMed ID: 34265321
[TBL] [Abstract][Full Text] [Related]
7. Statins in depression: a repurposed medical treatment can provide novel insights in mental health.
De Giorgi R; Cowen PJ; Harmer CJ
Int Rev Psychiatry; 2022; 34(7-8):699-714. PubMed ID: 36786109
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress.
Lin PY; Chang AY; Lin TK
Pharmacol Biochem Behav; 2014 Sep; 124():174-9. PubMed ID: 24931338
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.
De Giorgi R; Rizzo Pesci N; Rosso G; Maina G; Cowen PJ; Harmer CJ
Transl Psychiatry; 2023 Jul; 13(1):253. PubMed ID: 37438361
[TBL] [Abstract][Full Text] [Related]
10. The effects of statins on endothelium, inflammation and cardioprotection.
Elrod JW; Lefer DJ
Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
[TBL] [Abstract][Full Text] [Related]
11. Have statins changed the natural history of atheromatous disease and its treatment?
Samson RH
Semin Vasc Surg; 2008 Sep; 21(3):160-4. PubMed ID: 18774452
[TBL] [Abstract][Full Text] [Related]
12. Statins and the Brain: More than Lipid Lowering Agents?
Fracassi A; Marangoni M; Rosso P; Pallottini V; Fioramonti M; Siteni S; Segatto M
Curr Neuropharmacol; 2019; 17(1):59-83. PubMed ID: 28676012
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals.
Hayashi T; Kubota K; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Araki A; Noda M; Noto H; Sakuma I; Yoshizumi M; Ina K; Nomura H;
Int J Cardiol; 2014 Dec; 177(3):860-6. PubMed ID: 25466567
[TBL] [Abstract][Full Text] [Related]
14. Statins: the drugs for the 21st century?
Ginter E; Simko V
Bratisl Lek Listy; 2009; 110(10):664-8. PubMed ID: 20017462
[TBL] [Abstract][Full Text] [Related]
15. Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study.
Otte C; Zhao S; Whooley MA
J Clin Psychiatry; 2012 May; 73(5):610-5. PubMed ID: 22394433
[TBL] [Abstract][Full Text] [Related]
16. The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.
Saeedi Saravi SS; Saeedi Saravi SS; Arefidoust A; Dehpour AR
Metab Brain Dis; 2017 Aug; 32(4):949-965. PubMed ID: 28578514
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
18. Statins in stroke: prevention, protection and recovery.
Switzer JA; Hess DC
Expert Rev Neurother; 2006 Feb; 6(2):195-202. PubMed ID: 16466299
[TBL] [Abstract][Full Text] [Related]
19. Statins in heart failure. Beyond the lipid lowering effect.
Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
[TBL] [Abstract][Full Text] [Related]
20. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
